You should tip your hat to somebody who is a much better manipulator than you will ever be although you've been trying for years and years now. Nobody is even laughing at you anymore, just being bored with your untalent.
Who blinks first? So far people standing on the sidelines waiting for the settlement. As the deadline is nearing bets will be placed. When news of a favorable outcome spread the stock will be chased.
Two more questions:
If, theoretically speaking J&J were to appeal to the USPTO, how would that affect the six week period + a potential ruling?
If a settlement is reached, what can be the valuation of a cancelled anti trust case in that "package"?
dank, I didn't ask for delicate Information. I just wanted to know about the proceding and timeframe in general.
Someone wrote about six weeks time since there was no ruling. Is that an estimate or a fixed timeline?
And what happens if there was no settlement after this period? Will there be a ruling automatically?
This board is truely amazing. Piles of post dealing with clowns like goldstien and Aly but nobody has a clue about near future events.
if there is no settlement? Will Judge Orrick's hammer be crushing down on J&J?
Is this six weeks time frame fixed? Can anyone give a little clearance about procedures and time Frame?
I really don't understand why you all take part in a message board like ihub when it is obviously policy to place scam artists in a position as Moderators to manipulate the discussion in certain directions. Ihub deserves to be boycotted.
Geographically, Latin America home healthcare market is segmented as Brazil, Mexico, Argentina, Colombia and others. Brazil accounted for the largest market share and is expected to dominate the market during the forecast period from 2014 to 2020. Rising incidences of chronic diseases will drive the market growth of home healthcare in Brazil. For instance, the International Diabetes Federation (IDF) has estimated that the prevalence rate of diabetes in Brazil is expected to increase by 65% in the next two decades. Mexico contributed second largest share of the total market in 2013 and is expected to grow at the highest CAGR from 2014 to 2020. Introduction of technologically advanced devices by key players coupled with aging population will drive the growth of home healthcare in Mexico. In addition, factors such as increasing demand of home healthcare, increasing free trade agreement by government helps Argentina and Colombia market to grow consistently during the study period.
Manufacturers are introducing cost-effective and innovative home healthcare devices and services to attract more number of consumers. The Latin American home healthcare market includes major companies namely Johnson & Johnson, Medtronic, Inc., GE Healthcare, The Linde Group and others.
The home healthcare market comprises medical devices used for the diagnosis of various diseases such as diabetes, cardiovascular diseases, respiratory disorders and sleep disorders. The home healthcare market is witnessing steady growth in Latin America, as developed countries like North America and Europe are increasingly investing in this region. In addition, high acceptance of medical devices coupled with technological advancements (introduction of automated and portable devices) fuel the growth of the home healthcare market in Latin America. The home healthcare market, by device types, in Latin America is categorized as diagnostic and monitoring home healthcare devices (blood glucose monitors, blood pressure monitors, heart rate monitors, temperature monitors, sleep apnea monitors, coagulation monitors, pregnancy test kits, pulse oximeters and pedometers), therapeutic home healthcare devices (insulin delivery devices, nebulizers, medical ventilator and CPAP devices, intravenous equipment and dialysis equipment), mobility assist home healthcare devices (wheelchairs, cranes and crutches and other home mobility assist devices) and medical supplies. In 2013, medical supplies segment accounted for the largest share and is expected to grow at a CAGR of 6.7% during the forecast period from 2014 to 2020.
For example, according to United Nations, by 2050, the ratio of geriatric population with respect to the total population would increase to an average of 21% in Brazil, Mexico and Chile. In addition, new product development by key market players will further drive the growth of home healthcare market during the study period. For instance, in February 2014, Omron Healthcare, Inc. introduced Alvita ultimate pedometer. This device features tri-axis technology that enables accurate tracking of body movement - almost anywhere anytime. Additionally, it is integrated with auto-stride technology, which automatically calculates strides based on users' height and weight. Thus, introduction of technologically advanced devices drives the market growth of home healthcare devices.
ALBANY, New York, September 2, 2014 /PRNewswire/ --
According to a new market report published by Transparency Market Research "Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services: Rehabilitation, Telehealth and Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare Services) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" the Latin American Home Healthcare market was valued at USD 9.8 billion in 2013 and is estimated to reach a market worth of USD 17.5 billion in 2020 growing at a CAGR of 8.7% from 2014 to 2020.
Home healthcare market comprises medical devices and services that are used for the diagnosis and mitigation of variety of chronic diseases such as diabetes, respiratory infections, cardiovascular diseases and others. Home healthcare is widely used by disabled elderly population and patients with chronic diseases. Aging population will boost the market growth of home healthcare devices and services in Latin America.